Abbott Nutrition

Abbott Nutrition is the incumbent company context for Similac in Bobbie: Laura Modi. How a Baby Formula Startup Took Market Share From Two Industry Giants. The episode says Abbott’s 2022 Similac recall and facility shutdown contributed to the national formula shortage.

The source uses Abbott Nutrition as the incumbent-risk backdrop for Bobbie. The point is not a complete account of the recall, but the way a concentrated market can turn one large manufacturer’s problem into national scarcity, startup demand spikes, and pressure to protect existing subscribers.

Connections

• Similac, Enfamil, and Bobbie - incumbent brand, competing incumbent brand, and challenger.
• Infant Formula Market Concentration, Formula Supply Chain Resilience, and Trust As Business Asset - concepts sharpened by the shortage discussion.